A real-world prospective observational multi-national study in adult patients with breast cancer treated with extended adjuvant neratinib: NERLYFE study

被引：0
|
作者：
Bartsch, R. [1 ]
Baerens, D. -T [2 ]
Jegannathen, A. [3 ]
Youssef, B. [4 ]
Abdulkhalek, H. [5 ]
Davies, M. [6 ]
Smakal, M. [7 ]
Zimovjanova, M. [8 ]
Schmidt, M. [9 ]
Beghdad, F. [10 ]
Castagne, C. [10 ]
Zivanov, M. [10 ]
Harbeck, N. [11 ]
机构：
[1] Med Univ Vienna, Div Oncol, Dept Med 1, Clin Res Unit, Vienna, Austria
[2] Gynako Onkol Praxis, Ilsede, Austria
[3] Univ Hosp North Midlands NHS Trust Stoke On Trent, Dept Oncol, Stoke On Trent, Staffs, England
[4] Brustzentrum, Stadt Kliniken Monchengladbach, Monchengladbach, England
[5] Western Hlth & Social Care Trust, Londonderry, North Ireland
[6] Singleton Hosp, Swansea, W Glam, Wales
[7] Nemocnice Horovice, Onkol Oddeleni, Horovice, Czech Republic
[8] Gen Univ Hosp Prague, Prague, Czech Republic
[9] Univ Med Ctr Mainz, Dept Gynecol, Mainz, Germany
[10] Pierre Fabre, Boulogne, France
[11] LMU Univ Hosp, CCC Munich, Breast Ctr, Dept Obstet & Gynecol, Munich, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P313
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [21] First interim analysis from ELEANOR: A multi-national, prospective, non-interventional study (NIS) in patients with human epidermal growth factor receptor positive (HER2+) early breast cancer observing real-life extended adjuvant treatment with neratinib
    Luftner, Diana
    Bartsch, Rupert
    Breitenstein, Urs
    Balic, Marija
    Jackisch, Christian
    Muller, Volkmar
    Rinnerthaler, Gabriel
    Schmidt, Marcus
    Schwitter, Michael
    Zaman, Khalil
    Wrobel, Denise
    Guth, Dagmar
    Terhaag, Jurgen
    Zaiss, Matthias
    Schinkothe, Timo
    Harbeck, Nadia
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [22] Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study
    Zhang, Qiongwen
    He, Ping
    Tian, Tinglun
    Yan, Xi
    Huang, Juan
    Zhang, Zhang
    Zheng, Hong
    Zhong, Xiaorong
    Luo, Ting
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [23] TREATMENT SATISFACTION OF GUSELKUMAB FOR PLAQUE PSORIASIS PATIENTS IN A MULTI-NATIONAL, REAL-WORLD SETTING
    Molaei, M.
    Yang, F.
    Fitzgerald, T.
    Piercy, J.
    Lucas, J.
    Teneralli, R.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S479 - S479
  • [24] Extended adjuvant treatment of patients with HER2+early breast cancer with neratinib: a multi-centric, prospective, noninterventional study (NIS) in Germany and Austria (ELEANOR)
    Bartsch, R.
    Lueftner, D.
    Balic, M.
    Rinnerthaler, G.
    Jackisch, C.
    Mueller, V.
    Schmidt, M.
    Harbeck, N.
    [J]. BREAST, 2021, 56 : S18 - S18
  • [25] How breast cancer recurrences are found? A real-world, prospective cohort study
    Myller, S.
    Jukkola, A.
    Jaaskelainen, A.
    Roininen, N.
    Karihtala, P.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S81 - S82
  • [26] How breast cancer recurrences are found - a real-world, prospective cohort study
    Myller, Sylvia
    Jukkola, Arja
    Jaaskelainen, Anniina
    Roininen, Nelli
    Karihtala, Peeter
    [J]. ACTA ONCOLOGICA, 2022, 61 (04) : 417 - 424
  • [27] Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study
    Lee, Hyoung Cheol
    Cho, Soohyun
    Kim, Byung-Kun
    [J]. NEUROLOGICAL SCIENCES, 2023, 44 (07) : 2455 - 2463
  • [28] Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study
    Hyoung Cheol Lee
    Soohyun Cho
    Byung-Kun Kim
    [J]. Neurological Sciences, 2023, 44 : 2455 - 2463
  • [29] Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: A prospective study
    Gyenes, G
    Fornander, T
    Carlens, P
    Glas, U
    Rutqvist, LE
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (04): : 899 - 905
  • [30] Real-world assessment of quality-of-life in patients with breast cancer treated with adjuvant endocrine therapy
    Telli, Tugba Akin
    Ozturk, Mehmet Akif
    Alan, Ozkan
    Hasanov, Rahib
    Kostek, Osman
    Arikan, Rukiye
    Basoglu, Tugba
    Kaya, Serap
    Ercelep, Ozlem
    Babacan, Nalan Akgul
    Dane, Faysal
    Yumuk, Perran Fulden
    [J]. FUTURE ONCOLOGY, 2022, 18 (22) : 2425 - 2439
12345